Impact of Intraoperative Non-invasive Analgesia Monitoring Using Nociception Level Index on Patient Management

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorOsoian Cristiana

About this trial

This prospective randomised clinical trial aims to assess the impact of intraoperative nociception monitoring using NOL on anesthetic management during major abdominal surgery. Additionally, the study will objectively evaluate using NOL how intravenous lidocaine administration, influences opioid requirements and the effect of this multimodal approach on early postoperative outcomes. The investigators hypothesize that NOL-guided intraoperative opioid administration reduces both intraoperative and postoperative opioid use, positively influencing 24-hour outcomes. Furthermore, the addition of intraoperative lidocaine in NOL-guided analgesia may further decrease opioid consumption.

Eligibility criteria

Qualifiers

age > 18 years

ASA score I-III

surgery for gastric or hepatobiliary or pancreatic neoplasia

Disqualifiers

pregnancy

lactation

neuraxial or regional anesthesia

chronic treatment with drugs that can influence autonomic nervous system

Trial design

Treatments tested in this trial

  • Lidocaine Intravenous Infusion
  • NOL

Treatment groups

160 Participants
are divided into 4 treatment groups

Sponsors and collaborators

Osoian Cristiana

Lead sponsor

Iuliu Hatieganu University of Medicine and Pharmacy

Sponsor institution